Acer Therapeutics Inc

NASDAQ:ACER   4:00:00 PM EDT
1.63
+0.06 (+3.82%)
7:56:53 PM EDT: $1.62 -0.01 (-0.61%)
Earnings Announcements

Acer Therapeutics Reports Q3 2022 Financial Results

Published: 11/14/2022 22:47 GMT
Acer Therapeutics Inc (ACER) - Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update.
Acer Therapeutics Inc - Cash and Cash Equivalents Were $6.4 Million As of September 30, 2022, Compared to $12.7 Million As of December 31, 2021.
Acer Therapeutics Inc - Net Loss for Three Months Ended September 30, 2022 Was $5.0 Million, Or $0.31 Net Loss per Share.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.